Washington, United States | The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
It said GSK was the only company to make a bid for the contract, which will consist of supporting "military locations and personnel throughout the continental US and outside the continental US."
- Advertisement -
The work will be carried out in North Carolina "with an estimated completion date of Feb. 28, 2021," the Pentagon said.
The US Army will supervise execution of the project.
